← Open Payments lookup

ERIN FOX-HAMMEL: Open Payments

NPI 1609532373 · JOHNSTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$987 in 76 payments from 16 companies in 2025. Trend: 2023 $1,037 · 2024 $1,564 · 2025 $987

Food & beverage: $987
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$326
ABBVIE INC.27$235
Teva Pharmaceuticals USA, Inc.3$60
Neurocrine BioSciences, Inc.3$58
Corium, LLC4$57
Axsome Therapeutics, Inc.2$47
Vanda Pharmaceuticals Inc.1$34
Neos Therapeutics, LP2$29
Takeda Pharmaceuticals U.S.A., Inc.2$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24

Products named: VRAYLAR, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, INGREZZA, Azstarys, Auvelity, AUSTEDO XR.

Industry payments across IA — which companies pay providers there.